ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,090,225 | +120101.2% | 58,525 | +167114.3% | 0.00% | – |
| Q2 2023 | $907 | -56.7% | 35 | -52.1% | 0.00% | – |
| Q1 2023 | $2,095 | +4.8% | 73 | +2.8% | 0.00% | – |
| Q4 2022 | $2,000 | -98.9% | 71 | -99.1% | 0.00% | – |
| Q3 2022 | $180,000 | +39.5% | 7,553 | +30.5% | 0.00% | – |
| Q2 2022 | $129,000 | +163.3% | 5,786 | +195.5% | 0.00% | – |
| Q1 2022 | $49,000 | -23.4% | 1,958 | +8.2% | 0.00% | – |
| Q4 2021 | $64,000 | -7.2% | 1,810 | +9.6% | 0.00% | – |
| Q3 2021 | $69,000 | +165.4% | 1,652 | +169.1% | 0.00% | – |
| Q2 2021 | $26,000 | +2500.0% | 614 | +1515.8% | 0.00% | – |
| Q1 2021 | $1,000 | -98.6% | 38 | -97.5% | 0.00% | – |
| Q4 2020 | $69,000 | +430.8% | 1,550 | +318.9% | 0.00% | – |
| Q3 2020 | $13,000 | 0.0% | 370 | +3.9% | 0.00% | – |
| Q2 2020 | $13,000 | -13.3% | 356 | -26.7% | 0.00% | – |
| Q1 2020 | $15,000 | – | 486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |